Used in pharmaceutical research as a key intermediate in the synthesis of serotonin receptor modulators. Shows potential in the development of central nervous system agents, particularly for treating neurological disorders such as depression, anxiety, and migraine. Its structure supports binding affinity to 5-HT receptors, making it valuable in designing selective drugs. Also explored in the study of tryptamine derivatives for their psychoactive and therapeutic effects.